CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 124 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1 | -50.0% | 712 | 0.0% | 0.00% | – |
| Q1 2024 | $2 | +100.0% | 712 | 0.0% | 0.00% | – |
| Q4 2023 | $1 | 0.0% | 712 | 0.0% | 0.00% | – |
| Q3 2023 | $1 | 0.0% | 712 | 0.0% | 0.00% | – |
| Q2 2023 | $1 | 0.0% | 712 | 0.0% | 0.00% | – |
| Q1 2023 | $1 | 0.0% | 712 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -99.9% | 712 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 712 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 712 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -33.3% | 712 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -25.0% | 712 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | -20.0% | 712 | 0.0% | 0.00% | – |
| Q2 2021 | $5,000 | -16.7% | 712 | 0.0% | 0.00% | – |
| Q1 2021 | $6,000 | +20.0% | 712 | 0.0% | 0.00% | – |
| Q4 2020 | $5,000 | 0.0% | 712 | 0.0% | 0.00% | – |
| Q3 2020 | $5,000 | -80.0% | 712 | -75.9% | 0.00% | -100.0% |
| Q2 2020 | $25,000 | – | 2,958 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,559,722 | $23,672,000 | 1.29% |
| Congress Park Capital LLC | 78,561 | $522,000 | 0.32% |
| Exane Asset Management | 63,820 | $424,403,000 | 0.28% |
| Perceptive Advisors | 2,577,043 | $17,137,000 | 0.25% |
| RTW INVESTMENTS, LP | 1,526,003 | $10,148,000 | 0.24% |
| Jackson Creek Investment Advisors LLC | 80,504 | $535,000 | 0.24% |
| HARBOURVEST PARTNERS LLC | 79,193 | $527,000 | 0.20% |
| TANG CAPITAL MANAGEMENT LLC | 112,880 | $751,000 | 0.14% |
| Virtus ETF Advisers LLC | 38,721 | $257,000 | 0.14% |
| GLOBEFLEX CAPITAL L P | 69,435 | $462,000 | 0.12% |